Publication: HTLV-I antibody screening in donated blood and thalassemic patients.
dc.contributor.author | P. Chiewsilp | en_US |
dc.contributor.author | W. Iamsilp | en_US |
dc.contributor.author | P. Hathirat | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.date.accessioned | 2018-08-10T08:57:17Z | |
dc.date.available | 2018-08-10T08:57:17Z | |
dc.date.issued | 1993-10-01 | en_US |
dc.description.abstract | The HTLV-I antibody screening by passive partial agglutination test, Serodia HTLV-I (Fuji-rebio Inc) was performed in a total of 1,225 male and 468 female blood donors from September 1992 to March 1993. In addition, a total of 64 multitransfused thalassemic patients were also studied. All of the sera from donors and patients in both study groups showed no reactive results for HTLV-I antibody. This finding indicated that the HTLV-I infection is not yet a problem in blood transfusion in Thailand. However, the scattered reports of HTLV-I infections from our region should urge the national authority on the surveillance of this infection by epidemiological survey and occasional screening in blood donors. | en_US |
dc.identifier.citation | Journal of the Medical Association of Thailand. Vol.76 Suppl 2, (1993), 103-105 | en_US |
dc.identifier.issn | 01252208 | en_US |
dc.identifier.other | 2-s2.0-0027686974 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/22666 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0027686974&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | HTLV-I antibody screening in donated blood and thalassemic patients. | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0027686974&origin=inward | en_US |